Kato-Katz versus urine POC-CCA for the diagnosis of <em>Schistosoma mansoni </em>in preschool-aged children in Homa Bay County, Kenya (Publications)
6%; 95% CI, 49.1-65.8) was significantly lower than that of POC-CCA (73.2%; 95% CI, 65.0-80.4); χm2 = 5.88, p = 0.015. There was moderate agreement between KK and the combined results (k = 0.599, p
Impact of COVID-19 on the utilization of HIV testing and linkage services in Sierra Leone: experience from three public health facilities in Freetown (Publications)
compared with pre-pandemic HTS (2019). Of the 8538 people tested for HIV in the three facilities, 4929 (57.5%) visited CH. Only 2249 people were tested for HIV in 2020 compared to 3825 in 2019 (difference: - 41
Outbreak of <em>Cryptosporidium hominis</em> following river flooding in the city of Halle (Saale), Germany, August 2013 (Publications)
95%-CI: 0.9-7.6). In multivariable analysis visits to the floodplain remained the sole risk factor (OR: 5.5; 95%-CI: 1.4-22). Only C.hominis of a single genotype (IbA9G2) was detected in stools. Oocysts were
Differential impact of malaria control interventions on <em>P. falciparum</em> and <em>P. vivax</em> infections in young Papua New Guinean children (Publications)
during (2008) and after scale-up of control interventions (2013). In each cohort, children aged 1-5 years were actively monitored for infection and illness. Incidence of malaria episodes, molecular force [...] vivax clinical episodes declined at rates comparable to P. falciparum between 2006, 2008 and 2013 (IR 2.5 to 1.1 to 0.2), while P. vivax molFOB (2006, 9.8; 2008, 12.1) and prevalence (2006, 59.6%; 2008, 65
State of deworming coverage and equity in low-income and middle-income countries using household health surveys: a spatiotemporal cross-sectional... (Publications)
preschool children was estimated at 33.0% (95% CI 32.9-33.1). The subnational coverage ranged from 0.5% to 87.5%, and within-country variation was greater than between-country variation. Of the 31 countries
Transfluthrin eave-positioned targeted insecticide (EPTI) reduces human landing rate (HLR) of pyrethroid resistant and susceptible malaria vectors in... (Publications)
insecticide (EPTI) depends on the resistance status of malaria vectors. METHODS: Ribbons treated with 5.25 g transfluthrin or untreated controls were used around the eaves of an experimental hut as EPTI inside [...] transfluthrin and mosquito strain on mosquito landing rates and 24-h mortality. RESULTS: EPTI treated with 5.25 g of either TG or EC transfluthrin significantly reduced HLR of all susceptible and resistant Anopheles
Incidence of <em>Plasmodium falciparum</em> malaria infection in 6-month to 45-year-olds on selected areas of Bioko Island, Equatorial Guinea (Publications)
lds, 0.26 in 5-17-year-olds, 0.20 in 18-45-year-olds). Incidence of first malaria with symptoms was 0.13 [95% CI (0.09, 0.19)] per person per 24 weeks (0.16 in 6-59-month-olds, 0.10 in 5-17-year-olds,
Prevalence of sero-markers and non-invasive assessment of liver cirrhosis in patients with hepatitis B virus infection in Freetown, Sierra Leone: a... (Publications)
chronic infection (or inactive HBsAg carrier phase), 24.5% were in the HBeAg-negative immune active phase, 3.1% had HBeAg positive hepatitis, and 2.5% were HBsAg negative. The median Aspartate aminotransferase
Impact of road traffic noise on obesity measures: observational study of three European cohorts (Publications)
from a standardised European noise assessment framework. Residential exposures to NO2 for 2007 and PM2.5 for 2010 were estimated from Europe-wide land use regression models. Obesity markers including body [...] associations were robust to most other sensitivity analyses but attenuated by further adjustment of PM2.5 or area-level socioeconomic status. Associations were more pronounced among women, those with low physical
COVID-19 vaccine booster strategies in light of emerging viral variants: frequency, timing, and target groups (Publications)
(60+ or living with comorbidities) or (2) those 5+, at universal (98% of eligible) or lower coverage (85% of those 50+ or with comorbidities and 50% of 5-49 year olds) representing moderate vaccine fatigue
